PRESS RELEASE
News
-
-
PRESS RELEASE
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
Ipsen appoints Olivia Brown as EVP, Global Head of Neurotoxins, leading strategic growth in therapeutic and aesthetic neurotoxins market. Olivia brings 20 years of pharmaceutical and aesthetics leadership experience -
-
PRESS RELEASE
VIB Vermögen AG with strong key financial figures 2024 – successful implementation of the diversification strategy
VIB Vermögen AG achieved strong financial performance in 2024 with successful diversification. Gross rental income increased to EUR 88.9 million, FFO by 10%. Office asset class strengthened for future growth -
PRESS RELEASE
Klöckner & Co delivers robust operating income in fiscal year 2024 and continues to consistently implement the Group strategy
Klöckner & Co SE reports robust operating income of €136 million in fiscal year 2024. Focus on higher value-added business areas and sustainable steel industry positioning -
PRESS RELEASE
Branicks annual and consolidated financial statements for 2024: reliably on track in operational and structural terms
Branicks Group AG publishes successful 2024 annual and consolidated financial statements, focusing on operational stability, financial consolidation progress, and active market participation -
-
-
PRESS RELEASE
Avolta delivers a strong set of 2024 financials with revenue growth of +8.9% CER, a 9.4% CORE EBITDA margin and CHF 425m Equity Free Cash Flow, +32% YoY
Avolta reports strong 2024 financial results, including +8.9% revenue growth and CHF 425m Equity Free Cash Flow. Management focuses on shareholder value creation through business growth and capital allocation -
PRESS RELEASE
abrdn Japan Equity Fund, Inc. (“JEQ”) Announces A Proposed Merger Into abrdn Global Infrastructure Income Fund (“ASGI”) And A Conditional Tender Offer
abrdn Japan Equity Fund (JEQ) to merge into abrdn Global Infrastructure Income Fund (ASGI) subject to shareholder approval. JEQ board also approves conditional tender offer post-merger
